Decision Analysis & Portfolio Management for Biopharma Master Class
( 大师课程:关于生物医药品厂商的决策分析以及投资组合管理 )


此大师课程的特征 :

前一个讲座的主题为:根据充分理由所下的决策、经济面、投资组合理论,接下来是实习课程,使用具有决策树、以及投资组合优化功能的Excel外挂软体,进行决策分析以及投资组合管理。

在大师课程中所学得的决策手法,能在充满风险以及不确定性当中执行治理的相关决策。此外,学习经济及投资组合原则后,在重新检视投资组合、以及进行经营相关决策的准备及分析上,派上用场。

跟一些聚焦于创造价值以及设定专案优先顺序的讲座不同,本大师课程使用综合投资组合管理框架CREOPM的最新管理法,进行高度透明并且适当的决策、以及为了将投资组合的价值提高到最大值的全面手法。

藉由参加此大师课程,能够学习到如何使用具有说服力的实践性决策及投资组合分析手法,将企业的战略目标及财务目标明确化,为决策带来影响的方法。

大师课堂的主题为 :

  • 使用有实际成效的CREOPMTM框架阶段性手法,达到短、中、长期的成功,进行研究开发投资组合之定位。
  • 非判断项目及判断项目的专案分类及投资计画制作。
  • 在风险分析以及专案成功进行全面的可能性做出评价。
  • 将利益、风险、经费、时间等四个重要指标作为资源评价。
  • 透过优化投资组合活用有限预算及人力资源。
  • 使用定量、定性的判断基准设定专案优先顺序。
  • 在风险及不确定性存在情况下,进行风险、资源、股东的管理及改善决策。

推荐与会人士 :

  • 研究
  • 临床开发
  • 专案管理、方案管理、投资组合管理
  • 资源管理
  • 关于预测及竞争环境之情报收集
  • 行销
  • 提供执照与事业开发
  • 财务

请注意:顾问无法参加

Separate registration required. CHI requests that the Master Class not be interrupted once it begins. We ask that attendees commit to attending the entire program so as to not disturb the hands-on style instruction being offered to other participants.

ABOUT YOUR MASTER CLASS LEADER:

Dr. Richard Bayney is President & Founder of Project & Portfolio Value Creation, a consulting boutique providing training and education in project, program, portfolio, resource, and risk management as well as client services in strategic, business, and portfolio planning. He is an adjunct faculty member at the University of Pennsylvania. Dr. Bayney is a 23-year veteran of the Pharmaceutical & Biotechnology industry at Merck & Co., Inc., Bayer AG, Bristol-Myers Squibb, and Johnson & Johnson Pharmaceutical Research & Development. He obtained his MSc and PhD from University of London, MBA from Columbia University, and PMP from the Project Management Institute. In his last corporate position, Dr. Bayney was Head of Decision Analysis & Portfolio Management at Johnson & Johnson Pharmaceutical Research & Development.

第1天 – 决策分析

7:30–8:00 am Registration

8:00–9:00 am Session 1: Introduction – Agenda, background, and goals for masterclass; review of Decision Analysis & Portfolio Management survey

9:00–10:15 am Session 2: Decision making under risk and uncertainty – The value of decision framing and the Decision Quality cycle

10:15–10:30 am COFFEE/TEA BREAK

10:30 am–12:00 pm Session 3: Introduction to Decision Analysis and Precision Tree – A discipline oriented toward strategy selection on the basis of eNPV maximization under conditions of risk and uncertainty; calculating eNPV using Decision Trees

12:00–1:00 pm LUNCH

1:00–2:00 pm Session 4: Risk Analysis & Risk Management – Phase-dependent risk decomposition, value of imperfect information, SME risk elicitation, biases

2:00–3:30 pm Session 5: Deterministic integrated asset valuation – Structuring single- and multiple-asset Decision Trees to conduct project and program valuations and conducting sensitivity analysis

3:30–3:45 pm COFFEE/TEA BREAK

3:45–5:00 pm Session 6: Stochastic integrated asset valuation – Incorporating commercial uncertainty into Decision Trees with @ Risk and simulating ranges of eNPVs to select the dominant strategy

第2天 – 投资组合管理

8:00–9:30 am Session 7: CREOPMTM – A holistic Portfolio Management framework oriented toward portfolio value maximization and capability maturation

9:30–10:15 am Session 8: Strategic, Portfolio, and Business Plans – The importance of actionable and interdependent strategic, portfolio, and business plans

10:15–10:30 am COFFEE/TEA BREAK

10:30 am–12:00 pm Session 9: Project prioritization – Searching for the best rank order of projects to create portfolio value within defined resource constraints using Multiple Objective Decision Analysis (MODA)

12:00–1:00 pm LUNCH

1:00–2:30 pm Session 10: Deterministic portfolio optimization – Searching for the best combination of projects to maximize portfolio value within defined resource constraints using linear programming

2:30–2:45 pm COFFEE/TEA BREAK

2:45–4:00 pm Session 11: Stochastic portfolio optimization – Searching for the best combination of projects to maximize portfolio value within defined resource constraints and incorporating commercial uncertainty using stochastic programming

4:00–4:45 pm Session 12: Decision Analysis & Portfolio Management Capability Maturity Models –Diagnosis of organizational Decision Analysis and Portfolio Management capability models

4:45–5:00 pm Session 13: Wrap up and final Q&A – Final questions and AOB


* 活动内容有可能不事先告知作更动及调整。

Choose your language
Chinese
Japanese
Korean
English






免费电子邮件通知服务